Bromocriptine. Medical search

A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion.

A series of structurally-related alkaloids that contain the ergoline backbone structure.

A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate.

A pituitary adenoma which secretes PROLACTIN, leading to HYPERPROLACTINEMIA. Clinical manifestations include AMENORRHEA; GALACTORRHEA; IMPOTENCE; HEADACHE; visual disturbances; and CEREBROSPINAL FLUID RHINORRHEA.

An ergot derivative that acts as an agonist at dopamine D2 receptors (DOPAMINE AGONISTS). It may also act as an antagonist at dopamine D1 receptors, and as an agonist at some serotonin receptors (SEROTONIN RECEPTOR AGONISTS).

Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)

Drugs that bind to and activate dopamine receptors.

Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.

Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites.

Excessive or inappropriate LACTATION in females or males, and not necessarily related to PREGNANCY. Galactorrhea can occur either unilaterally or bilaterally, and be profuse or sparse. Its most common cause is HYPERPROLACTINEMIA.

A dopamine D2 antagonist that is used as an antiemetic.

A long-acting dopamine agonist which has been used to treat PARKINSON DISEASE and HYPERPROLACTINEMIA but withdrawn from some markets due to potential for HEART VALVE DISEASES.

Cell-surface proteins that bind dopamine with high affinity and trigger intracellular changes influencing the behavior of cells.

The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system.

A diphenylbutylpiperidine that is effective as an antipsychotic agent and as an alternative to HALOPERIDOL for the suppression of vocal and motor tics in patients with Tourette syndrome. Although the precise mechanism of action is unknown, blockade of postsynaptic dopamine receptors has been postulated. (From AMA Drug Evaluations Annual, 1994, p403)

A condition caused by prolonged exposure to excessive HUMAN GROWTH HORMONE in adults. It is characterized by bony enlargement of the FACE; lower jaw (PROGNATHISM); hands; FEET; HEAD; and THORAX. The most common etiology is a GROWTH HORMONE-SECRETING PITUITARY ADENOMA. (From Joynt, Clinical Neurology, 1992, Ch36, pp79-80)

A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.

A subfamily of G-PROTEIN-COUPLED RECEPTORS that bind the neurotransmitter DOPAMINE and modulate its effects. D2-class receptor genes contain INTRONS, and the receptors inhibit ADENYLYL CYCLASES.

A serotonin antagonist and a histamine H1 blocker used as antipruritic, appetite stimulant, antiallergic, and for the post-gastrectomy dumping syndrome, etc.

A syndrome characterized by a silent and inert state without voluntary motor activity despite preserved sensorimotor pathways and vigilance. Bilateral FRONTAL LOBE dysfunction involving the anterior cingulate gyrus and related brain injuries are associated with this condition. This may result in impaired abilities to communicate and initiate motor activities. (From Adams et al., Principles of Neurology, 6th ed, p348; Fortschr Neurol Psychiatr 1995 Feb;63(2):59-67)

Small clusters of chemoreceptive and supporting cells located near the ARCH OF THE AORTA; the PULMONARY ARTERIES; and the CORONARY ARTERIES. The aortic bodies sense PH; CARBON DIOXIDE; and OXYGEN concentrations in the BLOOD and participate in the control of RESPIRATION. The aortic bodies should not be confused with the PARA-AORTIC BODIES in the abdomen (which are sometimes also called aortic bodies).

Alkaloids originally isolated from the ergot fungus Claviceps purpurea (Hypocreaceae). They include compounds that are structurally related to ergoline (ERGOLINES) and ergotamine (ERGOTAMINES). Many of the ergot alkaloids act as alpha-adrenergic antagonists.

A group of corticosteroids bearing a hydroxy group at the 11-position.

Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.

Any drugs that are used for their effects on dopamine receptors, on the life cycle of dopamine, or on the survival of dopaminergic neurons.

A halogen with the atomic symbol Br, atomic number 36, and atomic weight 79.904. It is a volatile reddish-brown liquid that gives off suffocating vapors, is corrosive to the skin, and may cause severe gastroenteritis if ingested.

Absence of menstruation.

A polypeptide that is secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Growth hormone, also known as somatotropin, stimulates mitosis, cell differentiation and cell growth. Species-specific growth hormones have been synthesized.

Disturbances of MILK secretion in either SEX, not necessarily related to PREGNANCY.

A vasoconstrictor found in ergot of Central Europe. It is a serotonin agonist that has been used as an oxytocic agent and in the treatment of MIGRAINE DISORDERS.

Lists of words, usually in alphabetical order, giving information about form, pronunciation, etymology, grammar, and meaning.

Loss of the ability to maintain awareness of self and environment combined with markedly reduced responsiveness to environmental stimuli. (From Adams et al., Principles of Neurology, 6th ed, pp344-5)

A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH.

Drinkable liquids combined with or impregnated with carbon dioxide.

A plant genus of the family VALERIANACEAE, order Dipsacales, subclass Asteridae, class Magnoliopsida. It is best known for the sedative use and valepotriate content of the roots. It is sometimes called Garden Heliotrope but is unrelated to true Heliotrope (HELIOTROPIUM).

A sweet viscous liquid food, produced in the honey sacs of various bees from nectar collected from flowers. The nectar is ripened into honey by inversion of its sucrose sugar into fructose and glucose. It is somewhat acidic and has mild antiseptic properties, being sometimes used in the treatment of burns and lacerations.

Glucose in blood.

The only living genus of the order Equisetales, class Equisetopsida (Sphenopsida), division Equisetophyta (Sphenophyta); distantly related to ferns. It grows in moist places. The hollow, jointed, ridged stems contain SILICATES.

A genus of plant viruses in the family BUNYAVIRIDAE. Tomato spotted wilt virus is the type species. Transmission occurs by at least nine species of thrips.

A subset of various vascular plants (also known as the Tracheophyta) which include seed-bearing and non seed-bearing species.

A group of pyrido-indole compounds. Included are any points of fusion of pyridine with the five-membered ring of indole and any derivatives of these compounds. These are similar to CARBAZOLES which are benzo-indoles.

A loose confederation of computer communication networks around the world. The networks that make up the Internet are connected through several backbone networks. The Internet grew out of the US Government ARPAnet project and was designed to facilitate information exchange.

A professional society in the United States whose membership is composed of hospitals.

Organizations and individuals cooperating together toward a common goal at the local or grassroots level.

Institutional systems consisting of more than one health facility which have cooperative administrative arrangements through merger, affiliation, shared services, or other collective ventures.

It is a form of protection provided by law. In the United States this protection is granted to authors of original works of authorship, including literary, dramatic, musical, artistic, and certain other intellectual works. This protection is available to both published and unpublished works. (from Circular of the United States Copyright Office, 6/30/2008)

A malignant neoplasm of the lung composed chiefly or entirely of immature undifferentiated cells (i.e., blast forms) with little or virtually no stroma. (From Stedman, 25th ed)

Infections of the lungs with parasites, most commonly by parasitic worms (HELMINTHS).

Further or repeated use of equipment, instruments, devices, or materials. It includes additional use regardless of the original intent of the producer as to disposability or durability. It does not include the repeated use of fluids or solutions.

Infection with TREMATODA of the genus PARAGONIMUS.

Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine. (1/485)

LEK-8829 [9,10-didehydro-N-methyl-(2-propynyl)-6-methyl-8- aminomethylergoline bimaleinate] is an antagonist of dopamine D2 receptors and serotonin (5-HT)2 and 5-HT1A receptors in intact animals and a D1 receptor agonist in dopamine-depleted animals. In the present study, we used rats with unilateral striatal lesions with ibotenic acid (IA) to investigate the dopamine receptor activities of LEK-8829 in a model with innervated dopamine receptors. The IA-lesioned rats circled ipsilaterally when challenged with apomorphine, the mixed agonist on D1/D2 receptors. LEK-8829 induced a dose-dependent contralateral turning that was blocked by D1 receptor antagonist SCH-23390. The treatment with D1 receptor agonist SKF-82958 induced ipsilateral turning, whereas the treatment with D2 receptor antagonist haloperidol induced contralateral posture. The combined treatment with SKF-82958 and haloperidol resulted in a weak contralateral turning, indicating the possible receptor mechanism of contralateral turning induced by LEK-8829. Bromocriptine induced a weak ipsilateral turning that was blocked by haloperidol. The ipsilateral turning induced by bromocriptine was significantly potentiated by the coadministration of a low dose but not by a high dose of LEK-8829. The potentiation of turning was blocked either by SCH-23390 or by haloperidol. The potentiation of ipsilateral turning suggests the costimulation of D2 and D1 receptors by bromocriptine and LEK-8829, respectively, whereas the lack of potentiation by the highest dose of LEK-8829 may be explained by the opposing activity of LEK-8829 and bromocriptine at D2 receptors. We propose that the D2 and 5HT2 receptor-blocking and D1 receptor-stimulating profile of LEK-8829 is promising for the treatment of negative symptoms of schizophrenia. (+info)

Dopamine receptor subtypes modulate olfactory bulb gamma-aminobutyric acid type A receptors. (2/485)

The gamma-aminobutyric acid type A (GABAA) receptor is the predominant Cl- channel protein mediating inhibition in the olfactory bulb and elsewhere in the mammalian brain. The olfactory bulb is rich in neurons containing both GABA and dopamine. Dopamine D1 and D2 receptors are also highly expressed in this brain region with a distinct and complementary distribution pattern. This distribution suggests that dopamine may control the GABAergic inhibitory processing of odor signals, possibly via different signal-transduction mechanisms. We have observed that GABAA receptors in the rat olfactory bulb are differentially modulated by dopamine in a cell-specific manner. Dopamine reduced the currents through GABA-gated Cl- channels in the interneurons, presumably granule cells. This action was mediated via D1 receptors and involved phosphorylation of GABAA receptors by protein kinase A. Enhancement of GABA responses via activation of D2 dopamine receptors and phosphorylation of GABAA receptors by protein kinase C was observed in mitral/tufted cells. Decreasing or increasing the binding affinity for GABA appears to underlie the modulatory effects of dopamine via distinct receptor subtypes. This dual action of dopamine on inhibitory GABAA receptor function in the rat olfactory bulb could be instrumental in odor detection and discrimination, olfactory learning, and ultimately odotopic memory formation. (+info)

Kleine-Levin and Munchausen syndromes in a patient with recurrent acromegaly. (3/485)

Hypothalamic disease often affects the patients' personality and this also applies to pituitary tumors with suprasellar extension. We report on a patient with a 12-year history of recurrent acromegaly, treated with three transphenoidal operations, single field radiation therapy and bromocriptine/octreotide administration. During the course of follow-up she presented with self-inflicted anemia and Kleine-Levin syndrome (hypersomnia, hyperphagia and hypersexuality). Furthermore, she developed post-radiation necrosis within the right temporal lobe. Whether her neurological and personality disorders result - at least partially - from the acromegaly or the temporal lobe necrosis remains unclear. (+info)

The lipoprotein profile of women with hyperprolactinaemic amenorrhoea. (4/485)

The aim of this study was to evaluate the lipoprotein profile in women with hyperprolactinaemic amenorrhoea and to establish whether effective dopamine agonist therapy might have a beneficial effect. Blood samples were collected from women with hyperprolactinaemic amenorrhoea and from controls matched for age, body mass index and smoking. Follow-up blood samples were collected from women on dopamine agonist therapy as treatment for their hyperprolactinaemia. Plasma cholesterol, high density lipoprotein cholesterol, low density lipoprotein (LDL) cholesterol, very low density lipoprotein cholesterol, triglycerides, serum oestradiol and prolactin were measured. No statistically significant differences were found in the lipoprotein profile of the patient (n = 15) and control (n = 15) groups. During treatment with the dopamine agonist, bromocriptine (n = 9), significant reduction in total cholesterol [4.87 (3.98-5.87) versus 5.60 (4.55-6.61) mmol/l, P = 0.024] and LDL cholesterol [3.22 (2.01-4.23) versus 3.72 (2.59-4.93) mmol/l, P = 0.033] was noted. We conclude that beneficial alterations in the lipoprotein profile may occur in response to effective dopamine agonist therapy, presumably as a consequence of return of ovarian function and alleviation of oestrogen deficiency. Women with hyperprolactinaemic amenorrhoea should be encouraged to take effective therapy to improve their lipoprotein profile and potentially reduce their cardiovascular risk. (+info)

Tonic dopamine inhibition of L-type Ca2+ channel activity reduces alpha1D Ca2+ channel gene expression. (5/485)

Hormones and neurotransmitters have both short-term and long-term modulatory effects on the activity of voltage-gated Ca2+ channels. Although much is known about the signal transduction underlying short-term modulation, there is far less information on mechanisms that produce long-term effects. Here, the molecular basis of long-lasting suppression of Ca2+ channel current in pituitary melanotropes by chronic dopamine exposure is examined. Experiments involving in vivo and in vitro treatments with the dopaminergic drugs haloperidol, bromocriptine, and quinpirole show that D2 receptors persistently decrease alpha1D L-type Ca2+ channel mRNA and L-type Ca2+ channel current without altering channel gating properties. In contrast, another L-channel (alpha1C) mRNA and P/Q-channel (alpha1A) mRNA are unaffected. The downregulation of alpha1D mRNA does not require decreases in cAMP levels or P/Q-channel activity. However, it is mimicked and occluded by inhibition of L-type channels. Thus, interruption of the positive feedback between L-type Ca2+ channel activity and alpha1D gene expression can account for the long-lasting regulation of L-current produced by chronic activation of D2 dopamine receptors. (+info)

Reduction of plasma gonadotropin levels and pituitary tumor size by treatment with bromocriptine in a patient with gonadotropinoma. (6/485)

A pituitary tumor with suprasellar extension was found by magnetic resonance imaging (MRI) in a male with diabetes mellitus. Endocrine examination revealed high plasma follicle-stimulating hormone (FSH) and alpha-subunit levels, which increased with administration of thyrotropin (TSH)-releasing hormone (TRH). Plasma luteinizing hormone (LH) and testosterone levels were low. Pituitary gonadotropin producing tumor was diagnosed. Because the patient refused surgery, bromocriptine was administered and plasma FSH and alpha-subunit rapidly decreased; on MRI the tumor size was gradually reduced. When pituitary operation is not feasible, bromocriptine is one choice of treatment. (+info)

Stimulation of matrix-metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 gene expression in rats by the preovulatory prolactin peak. (7/485)

Since structural luteolysis involves deterioration of tissue, the gene expression of matrix-metalloproteinase-1 (MMP-1) and the respective tissue inhibitor of this metalloprotease (TIMP-1) were measured at various times on the day of pro-oestrus and in animals in which the preovulatory prolactin surge was blocked for the duration of 3 cycles by bromocriptine. An additional group of prolactin-blocked rats received a prolactin replacement injection on the afternoon of pro-oestrus. In spontaneously pro-oestrous rats, MMP-1 and TIMP-1 gene expression increased significantly (P<0.01) prior to the occurrence of the preovulatory LH surge but simultaneously with the onset of the preovulatory prolactin surge. When prolactin release was blocked by bromocriptine for 3 cycles, no such changes were observed during the afternoon of pro-oestrus. However, an intraperitoneal injection of bovine prolactin at the time when the preovulatory prolactin surge occurs normally, increased MMP-1 and TIMP-1 gene expression (P<0.01). These results indicate that MMP-1 and TIMP-1 gene expression are stimulated by the preovulatory prolactin surge. Previous work has shown that the preovulatory LH surge activates the enzymatic cascade which leads to increased collagenase activity. (+info)

Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa. (8/485)

Thirty-seven patients with Parkinsonism were treated with bromocriptine 2.5-300 mg daily. Bromocriptine, alone or combined with levodopa, caused a 20-30% reduction in disability scores in 11 patients treated for one year. Tolerance did not develop during this period. Bromocriptine treatment was not of value in six patients who had previously not responded or who had lost their response to levodopa. However, in four of five patients with response swings on levodopa due to rapid changes in plasma dopa levels, the addition of bromocriptine caused a more stable response. Dose response curves to bromocriptine 12.5, 25, 50, and 100 mg and to levodopa 250, 500, 1000, and 2000 mg were studied in seven patients. Levodopa 2 g had a greater therapeutic effect and caused a greater rise in plasma growth hormone concentration than bromocriptine 100 mg. Levodopa caused emesis more commonly and hallucinations less commonly than bromocriptine. Bromocriptine appears to be a less potent stimulant than dopamine, and has both pre- and post-synaptic effects. Metoclopramide 60 mg oral was given 30 minutes before bromocriptine or levodopa to establish whether this caused dopamine-receptor blockade. Metoclopramide acted as a competitive antagonist to the anti-Parkinsonism and growth hormone effect of both drugs and in individual cases prevented emesis and hallucinations. The fall in blood pressure due to bromocriptine or levodopa was not antagonised by metoclopramide. Central and peripheral vascular dopamine receptors may be different in nature. (+info)

... causes arterial/arteriolar vasodilation leading to a decrease in blood pressure by activating peripheral D1 receptors.[5] It decreases afterload and also promotes sodium excretion via specific dopamine receptors along the nephron. The renal effect of fenoldopam and dopamine may involve physiological antagonism of the renin-angiotensin system in the kidney.[6] In contrast to dopamine, fenoldopam is a selective D1 receptor agonist with no effect on beta adrenoceptors, although there is evidence that it may have some alpha-1 [7] and alpha-2 adrenoceptor antagonist activity.[5] D1 receptor stimulation activates adenylyl cyclase and raises intracellular cyclic AMP, resulting in vasodilation of most arterial beds, including renal, mesenteric, and coronary arteries.[8] to cause a reduction in systemic vascular resistance. Fenoldopam has a rapid onset of action (4 minutes) and short duration of action (, 10 minutes) and a linear dose-response relationship at usual clinical doses.[9] ...

https://en.wikipedia.org/wiki/Fenoldopam

Ergolines (e.g., 1P-LSD, ALD-52, bromocriptine, cabergoline, ergine (LSA), ergometrine (ergonovine), ergotamine, lisuride, LA- ... Ergolines (e.g., 2-Br-LSD (BOL-148), amesergide, bromocriptine, cabergoline, dihydroergotamine, ergotamine, LY-53857, LY- ... Ergolines (e.g., amesergide, bromocriptine, LY-53857, LY-215,840, mesulergine, metergoline, methysergide, sergolexole) ... Unknown/unsorted: Ergolines (e.g., 2-Br-LSD (BOL-148), bromocriptine, lergotrile, pergolide) ...

https://en.wikipedia.org/wiki/Captodiame

The hormone prolactin stimulates lactation (production of breast milk). Dopamine, released by the hypothalamus stops the release of prolactin from the pituitary gland. Domperidone, by acting as an anti-dopaminergic agent, results in increased prolactin secretion, and thus promotes lactation (that is, it is a galactogogue). In some nations, including Australia, domperidone is used off-label, based on uncertain and anecdotal evidence of its usefulness, as a therapy for mothers who are having difficulty breastfeeding.[24][25] In the United States, domperidone is not approved for this or any other use.[26][27] A study called the EMPOWER trial was designed to assess the effectiveness and safety of domperidone in assisting mothers of preterm babies to supply breast milk for their infants.[28] The study randomized 90 mothers of preterm babies to receive either domperidone 10 mg orally three times daily for 28 days (Group A) or placebo 10 mg orally three times daily for 14 days followed by domperidone ...

https://en.wikipedia.org/wiki/Domperidone

Djaldetti Ruth; Giladi Nir; Hassin-Baer Sharon; Shabtai Hertzel; Melamed Eldad (November-December 2003). "Pharmacokinetics of Etilevodopa Compared to Levodopa in Patient's With Parkinson's Disease: An Open-label, Randomized, Crossover Study". Clinical Neuropharmacology. 26 (6): 322-326. doi:10.1097/00002826-200311000-00012. PMID 14646613 ...

https://en.wikipedia.org/wiki/Etilevodopa

Melis MR, Succu S, Sanna F, Melis T, Mascia MS, Enguehard-Gueiffier C, Hubner H, Gmeiner P, Gueiffier A, Argiolas A (October 2006). "PIP3EA and PD-168077, two selective dopamine D4 receptor agonists, induce penile erection in male rats: site and mechanism of action in the brain". The European Journal of Neuroscience. 24 (7): 2021-30. doi:10.1111/j.1460-9568.2006.05043.x. PMID 17067298 ...

https://en.wikipedia.org/wiki/PD-168,077

The present meta-analysis was conducted to estimate the magnitude of the effects of methylphenidate and amphetamine on cognitive functions central to academic and occupational functioning, including inhibitory control, working memory, short-term episodic memory, and delayed episodic memory. In addition, we examined the evidence for publication bias. Forty-eight studies (total of 1,409 participants) were included in the analyses. We found evidence for small but significant stimulant enhancement effects on inhibitory control and short-term episodic memory. Small effects on working memory reached significance, based on one of our two analytical approaches. Effects on delayed episodic memory were medium in size. However, because the effects on long-term and working memory were qualified by evidence for publication bias, we conclude that the effect of amphetamine and methylphenidate on the examined facets of healthy cognition is probably modest overall. In some situations, a small advantage may be ...

https://en.wikipedia.org/wiki/Dopamine_receptor

... (MDPPP) is a stimulant designer drug. It was sold in Germany in the late 1990s and early 2000s as an ingredient in imitation ecstasy (MDMA) pills.[1] It shares a similar chemical structure with α-PPP and MDPV,[2][3][4] and has been shown to have reinforcing effects in rats.[5] ...

https://en.wikipedia.org/wiki/MDPPP

... is a synthetic compound that acts as a selective antagonist on D2 dopamine receptors.[1] Its selectivity to the cerebral D2 receptors is characterized by its respective Ki-values, which are as follows: 1.8, 3.5, 2400 and 18000 nM for D2, D3, D4 and D1 receptors respectively. It can be radiolabelled with radioisotopes, e.g. 3H or 11C and used as a tracer for in vitro imaging (autoradiography) as well as in vivo imaging positron emission tomography (PET). Images obtained by cerebral PET scanning (e.g. PET/CT or PET/MRI) allow the non-invasive assessment of the binding capacity of the cerebral D2 dopamine receptor, which can be useful for the diagnosis of movement disorders. In particular, cerebral D2 receptor binding as measured by carbon-11-raclopride (11C-raclopride) has shown to reflect disease severity of Huntington's disease, a genetical disease characterized by selective degeneration of cerebral D2 receptors.[2] Other studies have investigated the relationship of D2 receptor ...

https://en.wikipedia.org/wiki/Raclopride

In 1960 the Austrian biochemist Oleh Hornykiewicz, while at the University of Vienna, examined results of autopsies of patients who had died with Parkinson's disease. He suggested that the disease was associated with, or caused by, a reduction in the levels of dopamine in the basal ganglia of the brain. Since dopamine itself did not enter the brain, he tried treating twenty patients with a racemic mixture of dihydroxyphenylalanine (DOPA), which could enter the brain and be converted there to dopamine by the action of DOPA decarboxylase. His results were positive, as were those of another trial in Montreal run by André Barbeau. Unfortunately, other investigators were unable to replicate these early results, and the use of DOPA remained in question until 1967, when George Cotzias at the Brookhaven National Laboratories in Upton, New York, used megadoses of DOPA, up to 16 grams per day. Not long after these results became known, Curt Porter at Merck showed that L-DOPA was the active stereoisomer, ...

https://en.wikipedia.org/wiki/Carbidopa/levodopa

Bromocriptine. *Cabergoline. *Lisuride. *Pergolide. *Terguride. References[edit]. *^ Antonella Di Sarno; Maria Luisa Landi; ...

https://en.wikipedia.org/wiki/Quinagolide

... crosses the protective blood-brain barrier, whereas dopamine itself cannot. Thus, L-DOPA is used to increase dopamine concentrations in the treatment of Parkinson's disease and dopamine-responsive dystonia. This treatment was made practical and proven clinically by George Cotzias and his coworkers, for which they won the 1969 Lasker Prize.[4][5] Once L-DOPA has entered the central nervous system, it is converted into dopamine by the enzyme aromatic L-amino acid decarboxylase, also known as DOPA decarboxylase. Pyridoxal phosphate (vitamin B6) is a required cofactor in this reaction, and may occasionally be administered along with L-DOPA, usually in the form of pyridoxine.. Besides the central nervous system, L-DOPA is also converted into dopamine from within the peripheral nervous system. Excessive peripheral dopamine signaling causes many of the adverse side effects seen with sole L-DOPA administration. To bypass these effects, it is standard clinical practice to coadminister (with ...

https://en.wikipedia.org/wiki/L-dopa

BROMOCRIPTINE MESYLATE 69. BUDESONIDE 70. BULAQUINE 71. BUPIVA CAINE HYDROCHLORIDE 72. BUPROPION ...

https://en.wikipedia.org/wiki/Schedule_H

Bromocriptine (non-selective dopamine agonist). *Captodiame. *CJ-1639[17]. *compound R,R-16: 250x binding selectivity over D2[ ...

https://en.m.wikipedia.org/wiki/Dopamine_receptor_D3

"Bromocriptine and psychosis: A literature review". Psychiatric Quarterly. 66 (1): 87-95. doi:10.1007/BF02238717. PMID 7701022 ...

https://en.m.wikipedia.org/wiki/Hypersexuality

FDA moves to end use of bromocriptine for postpartum breast engorgement. 1994-08-17 [2009-09-22]. （原始内容存档于2007-12-23）.. ...

https://zh.wikipedia.org/wiki/母乳餵養

Lang, AE (1987). „Update on dopamine agonists in Parkinson's disease: "beyond bromocriptine"". The Canadian Journal of ...

https://sr.wikipedia.org/wiki/Ciladopa

Data from clinical studies have shown that DA agonists, such as bromocriptine, pramipexole and ropinirole, exhibit ...

https://en.wikipedia.org/wiki/Serotonin–norepinephrine–dopamine_reuptake_inhibitor

Treatment is usually medication with dopamine agonists such as cabergoline,[8] bromocriptine (often preferred when pregnancy is ... Colao A, Di Sarno A, Guerra E, De Leo M, Mentone A, Lombardi G (April 2006). "Drug insight: Cabergoline and bromocriptine in ... Kilicdag EB, Tarim E, Bagis T, Erkanli S, Aslan E, Ozsahin K, Kuscu E (June 2004). "Fructus agni casti and bromocriptine for ... "A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study ...

https://en.m.wikipedia.org/wiki/Hyperprolactinemia

The medication bromocriptine can reduce cravings and withdrawal symptoms within 24 hours.[35] ...

https://en.m.wikipedia.org/wiki/Khat

Kerr JL, Timpe EM, Petkewicz KA: Bromocriptine Mesylate for Glycemic Management in Type 2 Diabetes Mellitus, Annals of ... Holt RIG, Barnett AH, Bailey CJ: Bromocriptine: old drug, new formulation and new indication, Diabetes obesity & metabolism, ...

https://sl.wikipedia.org/wiki/Škrlatnordeča_glavnica

Bromocriptine as Palliative Therapy in Advanced Prostate Cancer: Experimental and Clinical Profile of a Drugjournal=Urologia ...

https://en.wikipedia.org/wiki/Polyestradiol_phosphate

Dopamine receptor agonists such as apomorphine, bromocriptine, cabergoline, dihydrexidine (LS-186,899), dopamine, fenoldopam, ...

https://en.wikipedia.org/wiki/Dopaminergic

... , Bromocriptine mesilate, Bromocriptine mesylate, Bromocriptine methanesulfonate, Bromocriptini mesilas, ... "Bromocriptine mesylate tablet label" (PDF). FDA. February 2017. Archived (PDF) from the original on 2018-05-13.. . For label ... "Bromocriptine mesylate tablets -- original uses" (PDF). FDA. January 2012. Archived (PDF) from the original on 2017-02-28.. For ... Bromocriptine (originally marketed as Parlodel, subsequently under many names)[1] is an ergoline derivative, is a dopamine ...

https://en.wikipedia.org/wiki/Bromocriptine

... (brand name Parkinsan) is an antiparkinson agent marketed for the treatment of Parkinson's disease.[2][3][1] While its exact mechanism of action is not well characterized,[2] it is believed to be an NMDA receptor antagonist,[4][5] but also promoting the synthesis of dopamine.[6] Because it provides additional benefits relative to existing treatments, it probably does not precisely mimic the mechanism of an existing known treatment.[6][7] ...

https://en.wikipedia.org/wiki/Budipine

Bromocriptine (semisynthetic). Br. CH(CH3)2. CH2CH(CH3)2. Leucine ... Drugs such as bromocriptine act as a dopamine receptor agonist, stimulating the nerves that control movement.[13] Newer ... Drugs such as bromocriptine interact with the dopaminergic receptor sites as agonists with selectivity for D2 receptors, making ...

https://en.wikipedia.org/wiki/Ergoline

Dopamine agonists include bromocriptine, pergolide, pramipexole, ropinirole, piribedil, cabergoline, apomorphine and lisuride. ...

https://en.wikipedia.org/?title=Parkinson's_disease

InChI=1S/C20H27N5O5S/c1-15-14-18(23-30-15)19(26)21-11-10-16-6-8-17(9-7-16)31(28,29)24-20(27)22-25-12-4-2-3-5-13-25/h6-9,14H,2-5,10-13H2,1H3,(H,21,26)(H2,22,24,27) ...

https://en.wikipedia.org/wiki/Glisoxepide

https://en.wikipedia.org/wiki/2,5-Dimethoxy-4-propylamphetamine

... is a potent and long lasting anticholinergic deliriant drug, related to the chemical warfare agent 3-Quinuclidinyl benzilate (QNB). It was developed under contract to Edgewood Arsenal during the 1960s as part of the US military chemical weapons program, during research to improve upon the properties of earlier agents such as QNB. The main advantages of EA-3443 were not only increased potency over QNB, but also a significantly improved central to peripheral effects ratio. Anticholinergic drugs produce both incapacitating deliriant effects through action in the brain, and a variety of distinctive physical symptoms such as dry mouth, dilated pupils, blurred vision and hot flushed skin, all of which together comprise the "anticholinergic syndrome" which is generally easy for doctors to diagnose. EA-3443 however is mainly selective for the brain, and when administered in a narrow dose range of around 0.3mg can produce the central effects of confusion, hallucinations and amnesia, but without ...

https://en.wikipedia.org/wiki/EA-3443

A list of US medications equivalent to Bromocriptine is available on the Drugs.com website. ... Bromocriptine is a medicine available in a number of countries worldwide. ... Bromocriptine Zentiva. Sanofi-Aventis, France. *Bromocriptine-Richter. Gedeon Richter, Bangladesh; Gedeon Richter, Malaysia; ... In the US, Bromocriptine (bromocriptine systemic) is a member of the following drug classes: dopaminergic antiparkinsonism ...

https://www.drugs.com/international/bromocriptine.html

Bromocriptine definition, an ergot derivative, C 32 H 40 BrN 5 O 5 , that inhibits prolactin and growth hormone secretions and ... bromocriptine in Medicine Expand. bromocriptine bro·mo·crip·tine (brōmō-krĭptēn). n. An ergot alkaloid that slows dopamine ...

http://www.dictionary.com/browse/bromocriptine

Bromocriptine belongs to the group of medicines known as ergot alkaloids. Bromocriptine blocks the release of a hormone called ... Information about this bromocriptine-oral-route. Pregnancy Category. Explanation. All Trimesters. B. Animal studies have ... Bromocriptine is also used together with a proper diet and exercise to treat high blood sugar levels in patients with type 2 ... Bromocriptine may cause dryness of the mouth. For temporary relief, use sugarless candy or gum, melt bits of ice in your mouth ...

https://www.mayoclinic.org/drugs-supplements/bromocriptine-oral-route/before-using/DRG-20062385?p=1

buy bromocriptine uk line. bromocriptine once buy uk. indian bromocriptine buy. can i buy bromocriptine online yahoo answers. ... bromocriptine where can i buy usa. bromocriptine canada to purchase. find cheap bromocriptine online. how to buy bromocriptine ... bromocriptine cheaper. bromocriptine generic where to buy. bromocriptine where buy online. bromocriptine extend buy. where can ... order bromocriptine from uk. bromocriptine 2.5 mg purchase uk. buying bromocriptine leeds. cheap bromocriptine alternative. and ...

http://lanyrd.com/profile/meipu1951739hn-4334/bio/

The worlds largest personalized health network that helps people find new treatments, connect with others and take action to improve their outcomes.

https://www.patientslikeme.com/treatment_evaluations/browse?condition_id=809&id=965-bromocriptine-side-effects-and-efficacy

Bromocriptine (BEC) is generally considered to be the agent of choice in the treatment of prolactinoma because of its long ... Bromocriptine (BEC) is generally considered to be the agent of choice in the treatment of prolactinoma because of its long ... encoded search term (What is the role of bromocriptine (BEC) in the treatment of prolactinomas?) and What is the role of ... What is the role of bromocriptine (BEC) in the treatment of prolactinomas?. Updated: Mar 25, 2018 ...

https://www.medscape.com/answers/124634-180802/what-is-the-role-of-bromocriptine-bec-in-the-treatment-of-prolactinomas

For best results, bromocriptine should be taken with food or milk. Storage. Store in a dry place away from heat and direct ... Bromocriptine reduces the bodys tolerance to alcohol. Pregnancy. If you are pregnant or plan to become pregnant, tell your ... In some cases bromocriptine may be used to treat acromegaly (overproduction of growth hormone, causing enlargement of the hands ... Bromocriptine blocks the pituitary from releasing the hormone prolactin, which is involved in the regulation of the menstrual ...

http://www.wholehealthmd.com/main/drugs/bromocriptine-mesylate-623.aspx

I found out almost 4 weeks ago that my Prolactin level is 25, had an MRI done and started Bromocriptine at that time. Befor... ... I never took Bromocriptine my endo doctor just waited to see if my levels would go down and they havent Ive been trying for ... I found out almost 4 weeks ago that my Prolactin level is 25, had an MRI done and started Bromocriptine at that time. Before ... I guess what Im wondering is since my cycles were pretty normal already will the Bromocriptine be enough to get me pregnant? I ...

http://www.medhelp.org/posts/Fertility---Infertility/High-Prolactin-Levels--Bromocriptine--and-a-normal-menstrual-cycle/show/1409546

Parlodel is another brand of bromocriptine that is not covered in this medication guide. The Cycloset brand of bromocriptine is ... This medication guide provides information about the Cycloset brand of bromocriptine. ... What is bromocriptine (Cycloset)?. This medication guide provides information about the Cycloset brand of bromocriptine. ... Bromocriptine lowers the hormone needed to produce breast milk. Do not breast-feed a baby while taking bromocriptine. ...

https://www.wellspan.org/health-library/Document.aspx?id=d00178a1

Antiprotin information about active ingredients, pharmaceutical forms and doses by Gulf Pharmaceutical Industries, Julphar, Antiprotin indications, usages and related health products lists

http://drugs-about.com/drugs-a/antiprotin.html

Bromocriptine for Inappropriate Thyrotropin Secretion JOHN M.C. CONNELL, M.B.; DOUGLAS C. MCCRUDEN, B.SC.; D.L. DAVIES, M.D.; W ... Bromocriptine for Inappropriate Thyrotropin Secretion. Ann Intern Med. 1982;96:251-252. doi: 10.7326/0003-4819-96-2-251 ... We write to report preliminary results of use of the dopamine agonist bromocriptine (Parlodel, Sandoz, Ltd, London, United ...

http://annals.org/aim/article-abstract/695351/bromocriptine-inappropriate-thyrotropin-secretion

Bromocriptine lowers the prolactin levels to normal (in most labs, the normal range is less than 20 ng/ml). It allows the ovary ... Bromocriptine is a drug thats used to treat women with hyperprolactinemia. In this condition, women cant ovulate as their ... Its best to take bromocriptine with meals. This helps reduce its side-effects and patients are able to tolerate it much better ... After starting bromocriptine, prolactin levels can be tested after at least one week of medication. This helps confirm that ...

https://www.drmalpani.com/knowledge-center/articles/bromocriptine-its-use-in-infertility-treatment

Bromocriptine has been reported to reduce A1C by 0.6% to 0.7% when taken alone or with other oral di ... Bromocriptine has been reported to reduce A1C by 0.6% to 0.7% when taken alone or with other oral diabetes drugs. It also has ...

https://www.sharecare.com/health/central-nervous-system-drugs/effective-bromocriptine-treatment-diabetes

Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes Subjects. The safety and scientific ... During these first 4 weeks, the daily dose of the study drug will be titrated up by one tablet (0.8 mg bromocriptine-QR) per ... A co-secondary objective of the study will be to assess the impact of Bromocriptine-QR vs Placebo on measures of insulin ... Active Comparator: Cycloset (Bromocriptine-QR) Subjects will be randomized in a 1:1 ratio to receive UDT (usual diabetes ...

https://www.clinicaltrials.gov/ct2/show/NCT02682901?term=cycloset&rank=5

... Ive read these are what to have on hand for potential deca gyno. Can they be located at the ... Bromocriptine i know IS NOT a controlled substance...do a search on yahoo for bromcriptine....i found an online pharmacy in the ...

http://forums.steroid.com/anabolic-steroids-questions-answers/60350-bromocriptine-dopergin-questions.html

Generic Bromocriptine tablets are used for treating Parkinson disease, menstrual problems, abnormal mil production in men and ... How will Bromocriptine work on my body? *How can the drug interactions and side effects of Bromocriptine be minimized or ... What does Bromocriptine treat?. Bromocriptine is a medication prescribed for a wide range of ailments such as Parkinsons ... Can I take Bromocriptine along with other drugs? *Are there certain foods, beverages and products to be avoided while on ...

http://www.internationaldrugmart.com/bromocriptine.html

... bromocriptine-QR) (11).. Bromocriptine is a dopamine D2 receptor agonist, and bromocriptine-QR was designed to provide a short ... Somnolence (4.3 bromocriptine-QR vs. 1.3% placebo) and hypoesthesia (1.4 bromocriptine-QR vs. 1.1% placebo) were the only AEs ... Bromocriptine-QR was developed to provide a discrete and brief daily interval of circulating bromocriptine at a particular time ... OBJECTIVE Quick-release bromocriptine (bromocriptine-QR), a D2 dopamine receptor agonist, is indicated as a treatment for type ...

http://care.diabetesjournals.org/content/33/7/1503

Initial bromocriptine did not change mortality in early, mild Parkinson disease Annals of Internal Medicine; 136 (3): 109 ... Bromocriptine Treatment of Prolactin-Secreting Pituitary Adenomas May Restore Pituitary Function ANNA WARFIELD, M.D., Ph.D.; ... Possible Bromocriptine-Induced Myocardial Infarction Annals of Internal Medicine; 118 (3): 199-200 ... Bromocriptine Treatment of Prolactin-Secreting Pituitary Adenomas May Restore Pituitary Function. Ann Intern Med. 1984;101:783- ...

http://annals.org/aim/article-abstract/699229/bromocriptine-treatment-prolactin-secreting-pituitary-adenomas-may-restore-pituitary-function

Bromocriptine) online without prescription on discount prices. Cheap online pharmacy: Women\s Health generic drugs and ... What To Discuss With My Health Care Provider Before Taking Parlodel (Bromocriptine)?. Since Parlodel (Bromocriptine) has been ... Prescribing Information for Parlodel (Bromocriptine):. What Is Parlodel (Bromocriptine)?. Parlodel, with Parlodel as its ... While Bromocriptine is not classified as detrimental to a growing fetus, this may be dangerous most especially if the pregnant ...

http://www.medformula.com/prescriptions/parlodel/

In patients with Parkinson disease who can tolerate bromocriptine, bromocriptine may be beneficial in delaying motor ... Review: Bromocriptine may be beneficial in delaying motor complications and dyskinesias in Parkinson disease PDF. ACP J Club. ... Bromocriptine versus levodopa in early Parkinsons disease. Cochrane Database Syst Rev. 2000;(3):CD002258 (latest version 22 ... In patients with Parkinson disease (PD), how effective is bromocriptine (BR) monotherapy for delaying the onset of motor ...

http://acpjc.org/Content/134/2/issue/ACPJC-2001-134-2-063.htm

Approach: The influence of chronic treatment with bromocriptine 20 mg kg day-1 i.p, sulpiride 20 mg kg day-1 i.p. or their ... Thus, bromocriptine induced hallucination is related to non dopaminergic action. Further, the results direct the attention to ... Results: Bromocriptine significantly decreased the plasma content of glutamic acid, glycine and alanine. (p,0.05, n = 7). ... Also, resultsindicate that bromocriptine decreased the brain content of taurine, glycine and aspartic acid. The mean % ...

http://thescipub.com/abstract/10.3844/ajptsp.2010.34.41

Bromocriptine, Bromocriptine mesilate, Bromocriptine mesylate, Bromocriptine methanesulfonate, Bromocriptini mesilas, ... "Bromocriptine mesylate tablet label" (PDF). FDA. February 2017. Archived (PDF) from the original on 2018-05-13.. . For label ... "Bromocriptine mesylate tablets -- original uses" (PDF). FDA. January 2012. Archived (PDF) from the original on 2017-02-28.. For ... Bromocriptine (originally marketed as Parlodel, subsequently under many names)[1] is an ergoline derivative, is a dopamine ...

https://en.wikipedia.org/wiki/Bromocriptine

Bromocriptine: learn about side effects, dosage, special precautions, and more on MedlinePlus ... Bromocriptine (Parlodel) comes as a capsule and a tablet to take by mouth. Bromocriptine (Cycloset) comes as a tablet to take ... Bromocriptine (Cycloset) is usually taken once a day with food within 2 hours of waking in the morning. Take bromocriptine at ... Before taking bromocriptine,. *tell your doctor and pharmacist if you are allergic to bromocriptine; ergot alkaloids such as ...

https://medlineplus.gov/druginfo/meds/a682079.html

Bromocriptine for idiopathic oligo/asthenospermia.. Vandekerckhove P1, Lilford R, Vail A, Hughes E. ... Bromocriptine appears to reduce prolactin levels in subfertile men with normal gonadotrophic function. There is not enough ... Whilst bromocriptine treatment for reducing prolactin levels in hyperprolactinaemic males (as in females), and, in the ... Compared with placebo, bromocriptine was associated with a significant reduction in serum prolactin levels (weighted mean ...

https://www.ncbi.nlm.nih.gov/pubmed/?term=10796498

... bromocriptine, edema - Answer: Swelling in your ankles or feet is a serious side effect of bromocriptine. ... ... Home › Q & A › Questions › Bromocriptine - Does it cause.... Bromocriptine - Does it cause edema?. Asked. 17 Sep 2009 by ... Side Effects of Bromocriptine (detailed). Search for questions. Still looking for answers? Try searching for what you seek or ... Did anyone try bromocriptine deratives it gave me vomitings. can anyone guide me with the dosages p?. Posted 22 Nov 2010 • 1 ...

https://www.drugs.com/answers/bromocriptine-does-it-cause-edema-85035.html

Bromocriptine oral tablet is a prescription drug. Its generic form and its brand-name version Parlodel are used to treat ... What is bromocriptine?. Bromocriptine is a prescription drug. It comes in the form of a tablet and a capsule you take by mouth. ... Highlights for bromocriptine. *Bromocriptine oral tablet is available as a generic drug and as brand-name drugs. Brand names: ... Bromocriptine side effects. Bromocriptine oral tablet can cause dizziness and drowsiness during the first few hours after you ...

https://www.healthline.com/health/bromocriptine-oral-tablet

WebMD provides information about interactions between Clarithromycin Oral and selected-macrolide-antibiotics-bromocriptine- ... Your doctor may not want you to take bromocriptine or cabergoline while you are taking your antifungal.If you experience nausea ... Bromocriptine; Cabergoline/Selected Macrolide Antibiotics Interactions. This information is generalized and not intended as ... 2.Cycloset (bromocriptine mesylate) tablets, US prescribing information. Veroscience LLC February 2, 2016. ...

https://www.webmd.com/drugs/2/drug-5030-7015/clarithromycin-oral/clarithromycin-oral/details/list-interaction-details/dmid-2720/dmtitle-selected-macrolide-antibiotics-bromocriptine-cabergoline/intrtype-drug

https://www.mskcc.org/cancer-care/patient-education/bromocriptine

Harmonised classification and labelling is a legally binding classification and labelling for a substance, agreed at European Community level. Harmonisation is based on the substances physical, toxicological and eco-toxicological hazard assessment. The Hazard classification and labelling section uses the signal word, pictogram(s) and hazard statements of the substance under the harmonised classification and labelling (CLH) as its primary source of information.. If the substance is covered by more than one CLH entry (e.g. disodium tetraborate EC no. 215-540-4, is covered by three harmonisations: 005-011-00-4; 005-011-01-1 and 005-011-02-9), CLH information cannot be displayed in the InfoCard as the difference between the CLH classifications requires manual interpretation or verification. If a substance is classified under multiple CLH entries, a link to the C&L Inventory is provided to allow users to view CLH information associated with the substance, instead of having the information ...

https://echa.europa.eu/substance-information/-/substanceinfo/100.042.829

Bromocriptine is taken in the morning. Drug: Bromocriptine Investigating the randomized order for timing of bromocriptine ... Bromocriptine is taken in te evening. Drug: Bromocriptine Investigating the randomized order for timing of bromocriptine ... Bromocriptine and Insulin Sensitivity (BIS). The safety and scientific validity of this study is the responsibility of the ... Bromocriptine, a dopamine 2 receptor agonist, has recently been approved in the treatment of type 2 diabetes mellitus(DM2). ...

https://www.clinicaltrials.gov/ct2/show/NCT02428946

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Centers RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.. ...

http://thorax.bmj.com/content/41/4/328

Effects of cocaine alone and with bromocriptine - Effects of cocaine alone and in combination with bromocriptine in human ... Bromocriptine (Parlodel, Cycloset), an ergoline derivative, is a dopamine agonist that is used in the treatment of pituitary ... In 2009, bromocriptine mesylate was approved by the FDA for treatment of type 2 diabetes under the trade name Cycloset ( ... Bromocriptine use has been associated with causing or worsening psychotic symptoms (its mechanism is in opposition of most ...

http://www.thefullwiki.org/Bromocriptine

Cycloset is another brand of bromocriptine that is not covered in this medication guide. The Parlodel brand of bromocriptine is ... This medication guide provides information about the Parlodel brand of bromocriptine. ... What is bromocriptine (Parlodel)?. This medication guide provides information about the Parlodel brand of bromocriptine. ... You should not use this medication if you are allergic to bromocriptine or to an ergot medicine (Ergomar, Cafergot, Migergot, D ...

https://www.wellspan.org/health-library/Document.aspx?id=d00178g1

Recently, bromocriptine is used in treatment of diabetes mellitus type II to improve insulin resistance. Objective: The aim of ... Case group was given bromocriptine 2.5 mg daily and placebo was given to control group. Patients were treated for 8 days and in ... bromocriptine reduced FBS and insulin levels and insulin resistance in PCO patients with pre-diabetes range. ... this study is the evaluation of bromocriptine on insulin resistance in PCO people. Patients and Methods: In this single-blind ...

https://www.scirp.org/journal/paperinformation.aspx?paperid=52744

... bromocriptine (Cycloset)) includes drug pictures, side effects, drug interactions, directions for use, symptoms of overdose, ... Generic Name: bromocriptine (Cycloset). *What is bromocriptine (Cycloset) (Cycloset)?. *What are the possible side effects of ... Bromocriptine lowers the hormone needed to produce breast milk. Do not breast-feed a baby while taking bromocriptine. ... You should not use this medication if you are allergic to bromocriptine or to an ergot medicine (Ergomar, Cafergot, Migergot, D ...

https://www.emedicinehealth.com/drug-bromocriptine/article_em.htm

What is bromocriptine mesylate? Meaning of bromocriptine mesylate medical term. What does bromocriptine mesylate mean? ... Looking for online definition of bromocriptine mesylate in the Medical Dictionary? bromocriptine mesylate explanation free. ... bromocriptine mesylate. Apo-Bromocriptine (CA), Cycloset, Dom-Bromocriptine (CA),Parlodel, PMS-Bromocriptine (CA) ... bromocriptine mesylate. Also found in: Dictionary, Encyclopedia.. Related to bromocriptine mesylate: hyperprolactinemia, ...

http://medical-dictionary.thefreedictionary.com/Bromocriptine+mesylate

If Bromocriptine was eventually administered to suppress lactation but afterwards the mother is willing to resuming ... Nor side effects occurred on 14 infants whose mothers received 2.5 mg of bromocriptine from 5th to 8th day after birth to treat ... 30 cases of galactorrhea-prolactinoma-hyperprolactinemia that were treated with a daily dose of 2.5 to 5 mg of Bromocriptine ... Is cabergoline an alternative to bromocriptine? Prescrire Int. 2015 Abstract *Serrano Aguayo P, García de Quirós Muñoz JM, ...

http://e-lactancia.org/breastfeeding/bromocriptine-mesilate/product/

Bromocriptine oral tablets (diabetes). What is this medicine?. BROMOCRIPTINE (broe moe KRIP teen) is used to treat type 2 ... an unusual or allergic reaction to bromocriptine, ergot alkaloids, other medicines, foods, dyes, or preservatives ...

http://www.ahealthyme.com/Library/DiseasesConditions/Adult/Endocrinology/121,81204

More than a year after the U.S. Food and Drug Administration approved Cycloset (bromocriptine mesylate) for treatment of type 2 diabetes, it's now available at pharmacies. (diabeticmediterraneandiet.com)
Cycloset (generic name = bromocriptine mesylate) was just approved for treatment of type 2 diabetes by the U.S. Food and Drug Administration. (diabeticmediterraneandiet.com)
Under the supervision of our veteran medical practitioners, we are capable of supplying a broad array of Bromocriptine Mesylate . (aadityapharmachem.com)
Further, our resultant range of Bromocriptine Mesylate is delivered to the clientsâ€™ end with appropriate packaging options and at affordable rates. (aadityapharmachem.com)

This medication guide provides information about the Cycloset brand of bromocriptine. (wellspan.org)
What is bromocriptine (Cycloset)? (wellspan.org)
The Cycloset brand of bromocriptine is used together with diet and exercise to treat type 2 diabetes. (wellspan.org)
Update December 3, 2010: Cycloset is not the same formulation of bromocriptine used to treat other diseases. (diabeticmediterraneandiet.com)
Although the parent compound in Cycloset is bromocriptine the formulation is uniquely different from traditional formulations of bromocriptine. (diabeticmediterraneandiet.com)
A close inspection of the package insert of Cycloset vs. traditional formulations reveals one significant difference in that the absorption efficiency of Cycloset is 2-3 times greater than traditional formulations of bromocriptine. (diabeticmediterraneandiet.com)
QR-bromocriptine (Cycloset™) has recently been approved in the USA for the treatment of type 2 diabetes mellitus (T2DM). (diabeticmediterraneandiet.com)
Bromocriptine is a generic dopamine agonist that may also go by the brand names Parlodel, Cycloset, and Brotin. (youdrugstore.com)

During these first 4 weeks, the daily dose of the study drug will be titrated up by one tablet (0.8 mg bromocriptine- QR) per day on a weekly basis until a maximal tolerated dose of at least two tablets (1.6 mg/day bromocriptine- QR) and no more than four tablets (3.2 mg/per day b-QR) is achieved. (clinicaltrials.gov)

Q. Is bromocriptine better than cabergoline? (1mg.com)
Both Cabergoline and bromocriptine belong to the same class of drug known as dopamine agonists. (1mg.com)

Bromocriptine lowers the hormone needed to produce breast milk. (wellspan.org)
Bromocriptine lowers the prolactin levels to normal (in most labs, the normal range is less than 20 ng/ml). (drmalpani.com)
Phase II and III clinical studies show that QR-bromocriptine lowers glycated haemoglobin by 0.6-1.2% (7-13 mmol/mol) either as monotherapy or in combination with other antidiabetes medications. (diabeticmediterraneandiet.com)

This is an interventional, twenty-four week, randomized, double blind, placebo-controlled trial with bromocriptine QR in subjects with newly diagnosed and established type 2 diabetes mellitus (T2DM) to evaluate its effects on the cardiovascular and peripheral autonomic nervous system, as well as on inflammatory markers, the leptin/adiponectin system, hormonal levels of RAS and HPA axis, indices of insulin resistance, and measures of oxidative and nitrosative stress. (clinicaltrials.gov)

The primary endpoint is the effect of Bromocriptine QR on changes in autonomic function measured by assessing sympathetic and parasympathetic function using conventional measures of autonomic function, including power spectral analysis of heart rate as well as peripheral autonomic function using sudorimetry and laser scanning of peripheral microvascular autonomic control. (clinicaltrials.gov)
This case demonstrates that a dissociation of the inhibitory effect of bromocriptine on tumor size and prolactin level may rarely develop during the course of drug treatment in a patient with macroprolactinoma. (elsevier.com)

Appropriate studies have not been performed on the relationship of age to the effects of bromocriptine to treat acromegaly, Parkinson's disease, and type 2 diabetes in the pediatric population. (mayoclinic.org)

It's best to take bromocriptine with meals. (drmalpani.com)

Keep in mind that bromocriptine only suppresses an increased prolactin level while you are taking it. (drmalpani.com)
Bromocriptine treats increased prolactin level by decreasing the amount of prolactin in the body which helps in fertility and period problems. (1mg.com)
During continued treatment at the same dose of bromocriptine the plasma prolactin level remained normal, but after 8 months of treatment the patient suddenly complained of worsening of her visual fields, and magnetic resonance imaging indicated re-enlargement of the tumor. (elsevier.com)

Bromocriptine blocks the release of a hormone called prolactin from the pituitary gland. (mayoclinic.org)
Bromocriptine is also used to treat acromegaly (overproduction of growth hormone) and pituitary prolactinomas (tumors of the pituitary gland). (mayoclinic.org)

Your fertility doctor may prescribe Bromocriptine to treat infertility caused by hyperprolactinemia, but they may combine this drug with other fertility drugs or treatments. (youdrugstore.com)

Secondary endpoints will demonstrate the effects of dopaminergic activation with Bromocriptine-QR on the regulation of Hypothalamic-Pituitary-Axis (HPA) axis hormones, on the plasma levels of markers of inflammation and oxidative/nitrosative stress in newly diagnosed vs. established type 2 diabetes subjects. (clinicaltrials.gov)

I assume it's the same bromocriptine that's been available for years to treat Parkinson's disease and acromegaly. (diabeticmediterraneandiet.com)
Bromocriptine is an approved drug originally indicated for Parkinson's disease, acromegaly, hyperprolactinemia and galactorrhoea, and recently repositioned for diabetes mellitus. (biomedcentral.com)
By means of an in silico screening searching for approved small bioactive drugs that potentially induce differentiation of AML cells, bromocriptine, a drug originally indicated for Parkinson's disease, acromegaly, hyperprolactinemia and galactorrhoea, and recently repositioned for diabetes mellitus [ 7 , 8 ], was identified. (biomedcentral.com)

How effective is bromocriptine for the treatment of diabetes? (sharecare.com)

Bromocriptine is an ergot alkaloid dopamine D(2) receptor agonist that has been used extensively in the past to treat hyperprolactinaemia, galactorrhoea and Parkinsonism. (diabeticmediterraneandiet.com)
Although bromocriptine was originally described as a dopamine receptor agonist/antagonist [ 9 ], its mechanism of action for each disease is partially unknown. (biomedcentral.com)

Bromocriptine is used to treat certain menstrual problems (e.g., amenorrhea) in women and stops milk production in some men and women who have abnormal milk leakage. (mayoclinic.org)

Bromocriptine is a drug that's used to treat women with hyperprolactinemia. (drmalpani.com)

However, elderly patients are more likely to have confusion, hallucinations, or uncontrolled body movements, and age-related kidney, liver, or heart problems, which may require caution and an adjustment in the dose for patients receiving bromocriptine. (mayoclinic.org)

I updated my brief bromocriptine drug review of May 14, 2009. (diabeticmediterraneandiet.com)
Bromocriptine: old drug, new formulation and new indication. (diabeticmediterraneandiet.com)
Our results support the use of bromocriptine as an anti-AML drug in a repositioning setting and the further clinical validation of this preclinical study. (biomedcentral.com)
Your fertility doctor may start you on a low dose of Bromocriptine and then gradually increase the amount of drug you are taking, to help reduce side effects. (youdrugstore.com)
Q. Is bromocriptine a fertility drug/ increased fertility? (1mg.com)

Bromocriptine is also used together with a proper diet and exercise to treat high blood sugar levels in patients with type 2 diabetes. (mayoclinic.org)

This medical condition involving high levels of prolactin hormone in the body can interfere with fertility in both women and men, and prescribing Bromocriptine to reduce prolactin can help restore fertility. (youdrugstore.com)

When administered in the early morning at the start of the light phase, a new quick release (QR) formulation of bromocriptine appears to act centrally to reset circadian rhythms of hypothalamic dopamine and serotonin and improve insulin resistance and other metabolic abnormalities. (diabeticmediterraneandiet.com)

Bromocriptine (BEC) is generally considered to be the agent of choice in the treatment of prolactinoma because of its long track record and safety. (medscape.com)

Thus, a QR formulation of bromocriptine timed for peak delivery in the early morning may provide a novel neurally mediated approach to the control of hyperglycaemia in T2DM. (diabeticmediterraneandiet.com)

A co-secondary objective of the study will be to assess the impact of Bromocriptine-QR vs Placebo on measures of insulin resistance and glycemic control (e.g., oral glucose tolerance test (OGTT) glucose and insulin, Matsuda index, Homeostasis Model Assessment-insulin resistance (HOMA-IR), Hemoglobin A1c (HbA1c). (clinicaltrials.gov)

The patient responded well to bromocriptine (7.5 mg/day) with improvement of clinical symptoms and normalization of plasma prolactin within a few weeks. (elsevier.com)

Bromocriptine may cause side effects such as constipation and hair loss. (1mg.com)

Bromocriptine belongs to the group of medicines known as ergot alkaloids. (mayoclinic.org)

Anatomy1

Organisms4

Diseases14

Chemicals and Drugs24

Analytical, Diagnostic and Therapeutic Techniques and Equipment1

Anthropology, Education, Sociology and Social Phenomena2

Technology, Industry, Agriculture2

Information Science5

Health Care5

Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine. (1/485)

Dopamine receptor subtypes modulate olfactory bulb gamma-aminobutyric acid type A receptors. (2/485)

Kleine-Levin and Munchausen syndromes in a patient with recurrent acromegaly. (3/485)

The lipoprotein profile of women with hyperprolactinaemic amenorrhoea. (4/485)

Tonic dopamine inhibition of L-type Ca2+ channel activity reduces alpha1D Ca2+ channel gene expression. (5/485)

Reduction of plasma gonadotropin levels and pituitary tumor size by treatment with bromocriptine in a patient with gonadotropinoma. (6/485)

Stimulation of matrix-metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 gene expression in rats by the preovulatory prolactin peak. (7/485)

Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa. (8/485)

Bromocriptine

Ergolines

Prolactin

Prolactinoma

Lisuride

Hyperprolactinemia

Dopamine Agonists

Pituitary Neoplasms

Hormone Antagonists

Galactorrhea

Metoclopramide

Pergolide

Receptors, Dopamine

Levodopa

Pimozide

Acromegaly

Domperidone

Receptors, Dopamine D2

Lysergic Acid

Cyproheptadine

Akinetic Mutism

Aortic Bodies

Ergot Alkaloids

11-Hydroxycorticosteroids

Antiparkinson Agents

Dopamine Agents

Bromine

Amenorrhea

Growth Hormone

Lactation Disorders

Dictionaries, Medical

Ergotamine

Dictionaries as Topic

Unconsciousness

Hypoglycemia

Carbonated Beverages

Valerian

Honey

Blood Glucose

Equisetum

Tospovirus

Tracheobionta

Carbolines

Internet

American Hospital Association

Community Networks

Multi-Institutional Systems

Copyright

Pulmonary Blastoma

Pleural Diseases

Lung Diseases, Parasitic

Equipment Reuse

Paragonimiasis

Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine. (1/485)

Dopamine receptor subtypes modulate olfactory bulb gamma-aminobutyric acid type A receptors. (2/485)

Kleine-Levin and Munchausen syndromes in a patient with recurrent acromegaly. (3/485)

The lipoprotein profile of women with hyperprolactinaemic amenorrhoea. (4/485)

Tonic dopamine inhibition of L-type Ca2+ channel activity reduces alpha1D Ca2+ channel gene expression. (5/485)

Reduction of plasma gonadotropin levels and pituitary tumor size by treatment with bromocriptine in a patient with gonadotropinoma. (6/485)

Stimulation of matrix-metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 gene expression in rats by the preovulatory prolactin peak. (7/485)

Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa. (8/485)

Bromocriptine long term effects - bromocriptine dopamine - dostinex vs bromocriptine

Buy Bromocriptine safely. Bromocriptine Uk Purchase » South Wedding Dreams Social Network - Welcome to the Wonderful World of...

Bromocriptine Treatment of Prolactin-Secreting Pituitary Adenomas May Restore Pituitary Function | Annals of Internal Medicine ...

Global And China Bromocriptine Mesylate Industry 2014 Market Trend, Size, Share, Growth and Forecast ~ QYResearch China

Global And China Bromocriptine Mesylate Industry 2014 Market Trend, Size, Share, Growth and Forecast ~ QYResearch China

Bromocriptine 2.5 mg price / Revista pronto españa 2015

Bromocriptine Mesylate, Bromocriptine Mesylate Supplier, Mumbai, Maharashtra

Taurine Implicated in Bromocriptine Induced Hallucination: Glycine-Glutamic-Aspartic Implicated in Bromocriptine Induced...

Bromocriptine mesylate - patient information, description, dosage and directions.

Bromocriptine : usage, side effects, expert advice and bromocriptine based medicines | 1mg

Effects of bromocriptine on serum VEGF levels in women undergoing in vitro fertilisation - AdisInsight

Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine<...

Buy Bromocriptine Mesylate 2.5 mg 5 mg Online | YouDrugstore

The Combined Intervention of Therapy and Bromocriptine Mesylate to Improve Functional Performance After Brain Injury | American...

drugprescription4u - Buy Parlodel (Bromocriptine mesylate) Online Without Prescription Needed at drugprescription4u

bromocriptine (Cycloset) - WellSpan Health Library

Generic Parlodel - Generic Bromocriptine

Bromocriptine | Define Bromocriptine at Dictionary.com

Bromocriptine for Inappropriate Thyrotropin Secretion | Annals of Internal Medicine | American College of Physicians

$Buy online generic Parlodel (Bromocriptine) / Women\s Health / Prescription$ Buy online generic Parlodel (Bromocriptine) / Women\s Health / Prescription